Markets:

Overview

News

Currencies

International

Treasuries

Esperion Therapeutics, Inc. - Common Stock (NQ:ESPR)

3.660 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Esperion Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Esperion Therapeutics Stock Hits Near 1-Year High As Wall Street Sees Strong Risk-Reward Play On Demand For Cholesterol Drug ↗

November 25, 2025

Piper Sandler projected long-term growth backed by rising use of Esperion’s LDL-lowering therapies and expanding payer coverage.

Via Stocktwits

DoorDash Posts Downbeat Q3 Earnings, Joins elf Beauty, Duolingo, HubSpot And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

November 06, 2025

Via Benzinga

Esperion Therapeutics Inc (NASDAQ:ESPR) Reports Mixed Q3 2025 Results with Revenue Beat and Wider Loss ↗

November 06, 2025

Esperion's Q3 2025 shows strong revenue growth beating estimates, but a deeper loss led to a sharp stock sell-off. The company secured key patents and targets profitability in 2026.

Via Chartmill

Topics Intellectual Property

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Why Is Esperion Therapeutics Stock Sinking Premarket Today? ↗

October 08, 2025

Via Stocktwits

Esperion Shares Rally After Patent Litigation Settlement For Cholesterol Drugs ↗

October 03, 2025

Via Stocktwits

Topics Intellectual Property

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Why Snap Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

November 06, 2025

Via Benzinga

Dow Jumps Over 100 Points; US Crude Oil Inventories Increase ↗

October 08, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 08, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

October 08, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

What to Expect from Esperion Therapeutics's Earnings ↗

August 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 08, 2025

Via Benzinga

Penguin Solutions Posts Q4 Earnings, Joins Esperion Therapeutics, Joby Aviation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 08, 2025

Via Benzinga

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

October 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 07, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗

October 07, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Top 2 Health Care Stocks That May Plunge This Month ↗

September 05, 2025

Via Benzinga

Esperion (ESPR) Q2 Revenue Jumps 12% ↗

August 05, 2025

Via The Motley Fool

Esperion Therapeutics Inc (NASDAQ:ESPR) Beats Q2 2025 Revenue Forecasts and Reduces Losses Amid Strong Prescription Growth ↗

August 05, 2025

Esperion Therapeutics (ESPR) beats Q2 2025 revenue estimates with $82.4M, narrows losses, and sees 42% U.S. sales growth. Stock surges 12% pre-market.

Via Chartmill

Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead ↗

May 01, 2025

Regulus Therapeutics shares surged after Novartis announced a $1.7 billion acquisition, but analysts downgraded the stock citing limited upside. Retail sentiment remained bullish, with speculation of a...

Via Stocktwits

Topics Stocks

Esperion Therapeutics Retail Bulls Charge In As Stock Notches Best Day In 3 Months On Impressive Q4 ↗

March 04, 2025

CEO Sheldon Koenig expects to drive further revenue gains and reach operating profitability through the expansion of its bempedoic acid products in the U.S. and Europe and global expansion into key...

Via Stocktwits

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 07, 2024

Via Benzinga

Earnings Scheduled For March 4, 2025 ↗

March 04, 2025

Via Benzinga

ESPR Stock Earnings: Esperion Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 12, 2024

ESPR stock results show that Esperion Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket ↗

August 12, 2024

Via Benzinga

Wall Street's Top 10 Stock Calls This Week - Saturday, June 22 ↗

June 22, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of June 17-21, 2024.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.